2023 | Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry | Chang, Te Sheng; Huang, Chung Feng; Kuo, Hsing Tao; Lo, Ching Chu; Huang, Chien Wei; Chong, Lee Won; Cheng, Pin Nan; Yeh, Ming Lun; Peng, Cheng Yuan; Cheng, Chien Yu; Huang, Jee Fu; Bair, Ming Jong; Lin, Chih Lang; Yang, Chi Chieh; Wang, Szu Jen; Hsieh, Tsai Yuan; Lee, Tzong Hsi; Lee, Pei Lun; Wu, Wen Chih; Lin, Chih Lin; Su, Wei Wen; Yang, Sheng Shun; CHIA-CHI WANG ; Hu, Jui Ting; Mo, Lein Ray; CHUN-TING CHEN ; Huang, Yi Hsiang; Chang, Chun Chao; Huang, Chia Sheng; Chen, Guei Ying; Kao, Chien Neng; Tai, Chi Ming; CHUN-JEN LIU ; Lee, Mei Hsuan; Tsai, Pei Chien; Dai, Chia Yen; JIA-HORNG KAO ; Lin, Han Chieh; Chuang, Wang Long; Chen, Chi Yi; Tseng, Kuo Chih; Hung, Chao Hung; Yu, Ming Lung | Hepatology International | 3 | 3 | |